Erasca, Inc. (ERAS)
NASDAQ: ERAS · Real-Time Price · USD
2.640
-0.150 (-5.38%)
Nov 20, 2024, 4:00 PM EST - Market closed
Erasca Market Cap
Erasca has a market cap or net worth of $746.40 million as of November 21, 2024. Its market cap has increased by 108.54% in one year.
Market Cap
746.40M
Enterprise Value
336.04M
1-Year Change
108.54%
Ranking
Category
Stock Price
$2.64
Market Cap Chart
Since the IPO on July 16, 2021, Erasca's market cap has decreased from $1.86B to $746.40M, a decrease of -59.83%. That is a compound annual growth rate of -23.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 788.81M | 145.95% |
| Dec 29, 2023 | 320.72M | -50.41% |
| Dec 30, 2022 | 646.73M | -65.76% |
| Dec 31, 2021 | 1.89B | 1.66% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Castle Biosciences | 805.21M |
| Relay Therapeutics | 795.91M |
| Evolus | 793.10M |
| Autolus Therapeutics | 791.71M |
| AbCellera Biologics | 791.58M |
| Pliant Therapeutics | 784.40M |
| Cytek Biosciences | 782.52M |
| Cullinan Therapeutics | 781.41M |